| 英文名稱 | Aflibercept (VEGF Trap) | 
|---|---|
| 中文名稱 | 阿柏西普 | 阿普西柏 | 
| CAS號(hào) | 862111-32-8 | 
| 外觀 | Colorless to light yellow liquid | 
| 儲(chǔ)存條件 | - 20℃ 3 years,-80°C for long term | 
| 規(guī)格 | 庫(kù)存 | 目錄價(jià) | 會(huì)員專享價(jià) | 數(shù)量 | 
|---|---|---|---|---|
| 1 mg | 3-5days | ¥3000.00 | 登錄后可見(jiàn) | |
| 5 mg | 3-5days | ¥12500.00 | 登錄后可見(jiàn) | |
| 10 mg | 3-5days | ¥20000.00 | 登錄后可見(jiàn) | |
| 50 mg | 3-5days | ¥80000.00 | 登錄后可見(jiàn) | |
| 100 mg | 3-5days | ¥125000.00 | 登錄后可見(jiàn) | 
| 英文名稱 | Aflibercept (VEGF Trap) | 
|---|---|
| 中文名稱 | 阿柏西普 | 阿普西柏 | 
| CAS號(hào) | 862111-32-8 | 
| 外觀 | Colorless to light yellow liquid | 
| 儲(chǔ)存條件 | - 20℃ 3 years,-80°C for long term | 
Aflibercept (VEGF Trap) is a soluble decoy Rapidly and dose-dependently elevated BP in mice and markedly impaired endothelial-dependent relaxation (EDR) and resulted in NADPH oxidases 1 (NOX1)- and NADPH oxidases 4 (NOX4)-mediated generation of ROS, decreased the activation of protein kinase B (Akt) and endothelial nitric oxide synthase (eNOS) concurrently with a reduction in nitric oxide (NO) production and elevation of ET-1 levels in mouse aortas.